ProPhase Labs (PRPH) Net Income towards Common Stockholders: 2009-2024
Historic Net Income towards Common Stockholders for ProPhase Labs (PRPH) over the last 16 years, with Dec 2024 value amounting to -$3.8 million.
- ProPhase Labs' Net Income towards Common Stockholders fell 321.64% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year increase of 70.61%. This contributed to the annual value of -$3.8 million for FY2024, which is 854.98% down from last year.
- Latest data reveals that ProPhase Labs reported Net Income towards Common Stockholders of -$3.8 million as of FY2024, which was down 854.98% from -$402,000 recorded in FY2023.
- Over the past 5 years, ProPhase Labs' Net Income towards Common Stockholders peaked at $18.5 million during FY2022, and registered a low of -$3.8 million during FY2024.
- Over the past 3 years, ProPhase Labs' median Net Income towards Common Stockholders value was -$402,000 (recorded in 2023), while the average stood at $4.7 million.
- In the last 5 years, ProPhase Labs' Net Income towards Common Stockholders crashed by 5,212.50% in 2020 and then soared by 442.26% in 2021.
- Yearly analysis of 5 years shows ProPhase Labs' Net Income towards Common Stockholders stood at -$2.1 million in 2020, then spiked by 442.26% to $7.3 million in 2021, then soared by 153.86% to $18.5 million in 2022, then plummeted by 102.18% to -$402,000 in 2023, then plummeted by 854.98% to -$3.8 million in 2024.